Neural antibodies can specifically label and recognize molecules on nerve cells, enabling a more comprehensive understanding and study of the biological properties, functions, and mechanisms of nerve cells in neurodegenerative diseases.
Covering iPSC neural cells, brain organoids, and microelectrode array services, our tools support neural development, disease modeling, and drug screening with high quality and reliable performance to meet diverse research needs.
Human IL-11 Protein, His Tag (Cat. No. IL1-H5243) stimulates proliferation of STAT3 (Luc) HEK293 Reporter Cell. The specific activity of Human IL-11 Protein, His Tag is>8.00 x 10^3 U/mg (QC tested).
Loaded Human IL-11 Protein, His Tag (Cat. No. IL1-H5243) on HIS1K Biosensor, can bind Human IL-11 R alpha, Fc Tag (Cat. No. ILR-H5256) with an affinity constant of 0.177 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Immobilized Mouse IL-11 R alpha, His Tag (Cat. No. ILR-M52H9) at 5 μg/mL (100 μL/well) can bind Mouse IL-11 Protein, Fc Tag (Cat. No. IL1-M5243) with a linear range of 0.2-10 ng/mL (QC tested).
Interleukin-11 (IL-11) is a pleiotropic cytokine that stimulates megakaryocytopoiesis, resulting in increased production of platelets, as well as activating osteoclasts, inhibiting epithelial cell proliferation and apoptosis, and inhibiting macrophage mediator production. These functions may be particularly important in mediating the hematopoietic, osseous and mucosal protective effects of IL-11. The cytokine also possesses anti-inflammatory activity, and has been proposed as a therapeutic agent in the treatment of chronic inflammatory diseases, such as Crohn's disease and rheumatoid arthritis. Although IL-11 was initially believed to be restricted to mammals, subsequent studies demonstrated it to be expressed in fish. Despite close similarity in gene structure and conservation of key amino acids between fish and mammalian IL-11, they share relatively low overall amino acid identity and may not necessarily be functionally analogous.
Clinical and Translational Updates
공개 약품 정보
Name
Research Code
Research Phase
Company
First Brand Name
First Approved Country
First Indication
First Approved Company
First Approved Date
Indications
Clinical Trials
Recombinant human interleukin-11 (Hangzhou Jiuyuan Gene Engineering Co Ltd )